Trial Profile
First-in-man trial of DNX-04042
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Jun 2015
Price :
$35
*
At a glance
- Drugs DNX 04042 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 23 Jun 2015 New trial record